Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00LSI
|
||||
| Former ID |
DCL001252
|
||||
| Drug Name |
Vidofludimus
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Rheumatold arthritis; Inflammatory bowel disease [ICD9: 555, 556, 710-719, 714; ICD10:K50, K51, M00-M25, M05-M06] | Phase 2 | [551497] | ||
| Company |
4SC AG
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H18FNO4
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Dihydroorotate dehydrogenase | Target Info | Modulator | ||
| KEGG Pathway | Pyrimidine metabolism | ||||
| Metabolic pathways | |||||
| PANTHER Pathway | De novo pyrimidine ribonucleotides biosythesis | ||||
| PathWhiz Pathway | Pyrimidine Metabolism | ||||
| Reactome | Pyrimidine biosynthesis | ||||
| WikiPathways | Metabolism of nucleotides | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.